Atwood & Palmer’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,811
| Closed | -$28.5K | – | 458 |
|
|
2024
Q1 | $28.5K | Hold |
1,811
| – | – | ﹤0.01% | 253 |
|
|
2023
Q4 | $29.2K | Hold |
1,811
| – | – | ﹤0.01% | 257 |
|
|
2023
Q3 | $23K | Hold |
1,811
| – | – | ﹤0.01% | 262 |
|
|
2023
Q2 | $25.5K | Hold |
1,811
| – | – | ﹤0.01% | 258 |
|
|
2023
Q1 | $28K | Hold |
1,811
| – | – | ﹤0.01% | 241 |
|
|
2022
Q4 | $29.7K | Hold |
1,811
| – | – | ﹤0.01% | 252 |
|
|
2022
Q3 | $34K | Hold |
1,811
| – | – | ﹤0.01% | 225 |
|
|
2022
Q2 | $24K | Hold |
1,811
| – | – | ﹤0.01% | 277 |
|
|
2022
Q1 | $17K | Hold |
1,811
| – | – | ﹤0.01% | 336 |
|
|
2021
Q4 | $18K | Hold |
1,811
| – | – | ﹤0.01% | 326 |
|
|
2021
Q3 | $62K | Hold |
1,811
| – | – | 0.01% | 210 |
|
|
2021
Q2 | $66K | Hold |
1,811
| – | – | 0.01% | 210 |
|
|
2021
Q1 | $81K | Hold |
1,811
| – | – | 0.01% | 191 |
|
|
2020
Q4 | $103K | Hold |
1,811
| – | – | 0.01% | 170 |
|
|
2020
Q3 | $93K | Hold |
1,811
| – | – | 0.01% | 164 |
|
|
2020
Q2 | $108K | Hold |
1,811
| – | – | 0.01% | 156 |
|
|
2020
Q1 | $75K | Hold |
1,811
| – | – | 0.01% | 163 |
|
|
2019
Q4 | $113K | Hold |
1,811
| – | – | 0.01% | 152 |
|
|
2019
Q3 | $61K | Hold |
1,811
| – | – | 0.01% | 182 |
|
|
2019
Q2 | $41K | Hold |
1,811
| – | – | 0.01% | 187 |
|
|
2019
Q1 | $42K | Hold |
1,811
| – | – | 0.01% | 182 |
|
|
2018
Q4 | $38K | Hold |
1,811
| – | – | 0.01% | 179 |
|
|
2018
Q3 | $70K | Hold |
1,811
| – | – | 0.01% | 171 |
|
|
2018
Q2 | $71K | Buy |
+1,811
| New | +$53.3K | 0.01% | 170 |
|
Other funds holding DCPH
Atwood & Palmer's DCPH Position: Q2 2024 in Review
Atwood & Palmer sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 1,811 shares — an estimated $28.5K sold.
Atwood & Palmer first reported a position in DCPH in Q2 2018 and held it in 24 quarters. The position peaked at $113K in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Atwood & Palmer reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Atwood & Palmer sold 1,811 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $28.5K.
- Atwood & Palmer first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 24 quarters.
- Atwood & Palmer's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $113K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Atwood & Palmer's 13F filing for Q2 2024, filed 10 Jul 2024.